Navigation Links
Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office
Date:7/9/2008

CHICAGO, July 9 /PRNewswire/ -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the U.S., announces the opening of a new office in the Raleigh/Durham, North Carolina area and welcomes two local patent attorneys, Allen R. Baum and Joshua T. Elliott, who will be based in the Raleigh office. Mr. Baum and Mr. Elliott, formerly with The Hutchison Law Group, join the firm as partners. The office will officially be open for business on Tuesday, July 15, 2008.

"Brinks is a world leader in intellectual property law and already serves a solid client base in the Research Triangle Park (RTP) region," said Brinks president, Gary M. Ropski. "The addition of these two outstanding attorneys and the new office fits our current practice strategy and addresses an increasing demand from our clients. This expansion into the southeastern United States will allow us to build on our commitment to exceptional service to all clients."

The new Raleigh office will be located in the RTP area, one of the oldest and largest science parks in North America and home to more than 170 companies, including Fortune 100 multinational research organizations, university-based and start-up operations and a number of U.S. federal agencies.

"Josh and I are pleased to practice IP law with such a prominent and respected firm that is dedicated solely to intellectual property," said Mr. Baum. "Brinks offers us the capacity and resources to grow our prosecution practice, as well as expand our litigation service capabilities for clients we currently serve."

"Brinks has established a significant presence in the generic pharmaceutical segment," said Thomas J. Filarski, chair of the firm's Chemical Group and a lead generic pharmaceutical litigator. "The addition of Allen and Josh to our office in Raleigh will markedly enhance the scope of our pharmaceutical, chemical and biotech practice."

Allen R. Baum is a skilled patent attorney focusing his practice in the areas of pharmaceuticals, biochemistry and biotechnology. Prior to and during law school, Mr. Baum was a pharmaceutical chemist for DuPont Merck Pharmaceuticals and SmithKline Beecham. He is a past president of the Licensing Executives Society, an organization of more than 6,000 licensing professionals in the United States and Canada. He also served as the chair of the Chemical/Biotechnology Committee of the North Carolina Bar Association. Mr. Baum received his B.S. from Muhlenberg College, Allentown, PA, and his law degree from Widener University School of Law.

Joshua T. Elliott focuses his practice on patent law matters relating to biochemistry and biotechnology. His clients include technology companies involved in areas such as proteins, peptides, nucleic acids, antibodies, pharmaceuticals, proteomics and RNA interference. Mr. Elliott received his B.S. from the University of North Carolina at Chapel Hill, where he was elected a member of Phi Beta Kappa, and his law degree from the University of Dayton School of Law, where he was a Loren M. Berry Scholar and a member of the University of Dayton Law Review.

Founded in 1917, Brinks Hofer Gilson & Lione is based in Chicago with five other offices across the country serving the intellectual property needs of clients from around the world. The firm is one of the largest IP law firms in the country, with more than 170 attorneys, scientific advisors and patent agents specializing in intellectual property litigation and all aspects of patent, trademark, copyright, trade secret, unfair competition, intellectual asset management, and technology and licensing agreements. Brinks routinely handles assignments in fields as diverse as electrical, chemical, mechanical, biotechnology, pharmaceutical, nanotechnology, Internet and computer technology, as well as in trademarks and brand names for a wide variety of products and services. For additional information, visit http://www.usebrinks.com.

CONTACT:

Sydney Iglitzen

(312) 840-3163

siglitzen@usebrinks.com


'/>"/>
SOURCE Brinks Hofer Gilson & Lione
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Twenty-One Brinks Hofer Gilson & Lione Attorneys Named 2008 Illinois Super Lawyers
2. Fraunhofer and Boston University Hosted Prestigious SME Tour
3. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
4. Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board
5. SAFC Supply Solutions Expands Halal Offer in Flavors & Fragrances Product Line
6. PAREXEL Expands Global Clinical Logistics Capabilities
7. BioXcel Expands Its Capability in Business Analytics Support Services
8. Corgenix Expands Scientific Advisory Board
9. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
10. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
11. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):